ProBioSanus - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 202,476 | 292,927 | 299,357 | 214,935 | 198,586 | 220,783 | 127,356 | 20,748 |
| Profit before tax | -331,579 | -373,690 | -245,024 | 199,203 | -234,457 | -462,151 | -736,353 | -982,510 |
| Net profit | -283,547 | -320,638 | -210,930 | 167,787 | -198,919 | -397,292 | -627,993 | -833,936 |
| Equity | -495,880 | -816,518 | -221,387 | -53,100 | -252,019 | -649,311 | -1,277,304 | -166,416 |
| Liabilities | 936,742 | 1,283,489 | 755,349 | 861,414 | 910,320 | 1,245,272 | 1,993,455 | 1,154,976 |
| Non-current assets | 328,748 | 343,891 | 402,849 | 374,708 | 400,537 | 468,902 | 577,283 | 753,551 |
| Current assets | 101,052 | 95,103 | 110,504 | 420,137 | 244,218 | 132,334 | 148,596 | 238,835 |
| Total assets | 429,800 | 438,994 | 513,353 | 794,845 | 644,755 | 601,236 | 725,879 | 992,386 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 867 | 37,367 | 3,060 |
| Social insurance contributions | - | - | - | - | - | 58,039 | 101,396 | 92,412 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -9.0% | +44.7% | +2.2% | -28.2% | -7.6% | +11.2% | -42.3% | -83.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -66.0% | -73.0% | -41.1% | 21.1% | -30.9% | -66.1% | -86.5% | -84.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -140.0% | -109.5% | -70.5% | 78.1% | -100.2% | -179.9% | -493.1% | -4019.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -163.8% | -127.6% | -81.9% | 92.7% | -118.1% | -209.3% | -578.2% | -4735.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 28,585 | 35,506 | 38,627 | 25,537 | 22,914 | 19,060 | 8,129 | 1,741 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ProBioSanus - Social security debts
The company had no debts to Sodra
ProBioSanus - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ProBioSanus, UAB, code 302733890, is a Private Limited Liability Company operating in the manufacture of soap and detergents, cleaning and polishing preparations. In 2025, the company generated €20.7K in revenue, down from €127.4K in 2024 and €220.8K in 2023, confirming a sharp two-year contraction in turnover. Net loss increased to €833.9K in 2025, following losses of €628.0K in 2024 and €397.3K in 2023, so profitability continued to deteriorate. Total assets rose to €992.4K in 2025 from €725.9K a year earlier and €601.2K in 2023, supported mainly by long-term assets of €753.6K. Equity remained negative, improving from -€1.28M in 2024 to -€166.4K in 2025, while liabilities were still €1.15M. The company’s efficiency remained very weak, with asset turnover at 0.02x and returns on assets deeply negative. Revenue per employee was €1.9K, and profit per employee was -€75.8K, indicating limited productivity against a substantial cost base.